AbCellera Biologics (ABCL) PT Lowered to $5 at BMO Capital Nov 5, 2024 08:14AM
AbCellera Biologics (ABCL) PT Lowered to $49 at BMO Capital, Following Earnings Nov 10, 2021 02:27PM
Pay More Attention to AbCellera Biologics (ABCL) on String of Positive News, BMO Says; Analyst Sees ~150% Upside Sep 20, 2021 07:10AM
Pre-Open Stock Movers 09/17: (CRVS) (ABCL) (BGNE) Higher; (PTGX) (GRTS) (X) Lower (more...) Sep 17, 2021 09:28AM
AbCellera Biologics (ABCL) PT Raised to $61 at BMO Capital Jan 25, 2021 07:25AM


Jan 5, 2021 06:29AM UPDATE: BMO Capital Starts AbCellera Biologics (ABCL) at Outperform
Dec 15, 2020 09:03PM AbCellera Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Dec 11, 2020 11:55AM AbCellera Biologics (ABCL) IPO Opens 205% Higher
Dec 11, 2020 06:08AM AbCellera Biologics Inc. (ABCL) Prices 24.150M Share IPO at $20/Sh
Dec 10, 2020 10:47PM AbCellera Announces Pricing of Initial Public Offering